ВАКСНЬЮВАНС ВАКЦИНА ПНЕВМОКОКОВА ПОЛІСАХАРИДНА КОН'ЮГОВАНА (15-ВАЛЕНТНА, АДСОРБОВАНА)

उत्पाद अवलोकन

About ВАКСНЬЮВАНС ВАКЦИНА ПНЕВМОКОКОВА ПОЛІСАХАРИДНА КОН'ЮГОВАНА (15-ВАЛЕНТНА, АДСОРБОВАНА)

ВАКСНЬЮВАНС ВАКЦИНА ПНЕВМОКОКОВА ПОЛІСАХАРИДНА КОН'ЮГОВАНА (15-ВАЛЕНТНА, АДСОРБОВАНА) is a pneumococcal conjugate vaccine, designed to provide immunity against pneumococcal infections caused by Streptococcus pneumoniae. This vaccine is composed of purified polysaccharides antigens conjugated to a carrier protein, which stimulates the body's immune system to produce antibodies against the pneumococcus bacteria.

Key Benefits & Uses

• Protection against pneumococcal infections, including pneumonia, meningitis, and sepsis.
• Prevention of invasive pneumococcal disease (IPD) in individuals at high risk, such as older adults and those with certain underlying medical conditions.
• Induction of immune response against pneumococcal serotypes 1-15, which are the most common causes of pneumococcal disease.

Active Ingredient & Action

The active ingredient in ВАКСНЬЮВАНС ВАКЦИНА ПНЕВМОКОКОВА ПОЛІСАХАРИДНА КОН'ЮГОВАНА (15-ВАЛЕНТНА, АДСОРБОВАНА) is Pneumococcus, purified polysaccharides antigen conjugated. This conjugate vaccine works by stimulating the body's immune system to produce antibodies against the pneumococcus bacteria. The polysaccharide antigens are conjugated to a carrier protein, which enhances the immune response and provides long-term protection against pneumococcal infections.

Important Notes

Before administration, ensure that the individual has no history of severe allergic reactions to any component of the vaccine. Consult the product insert or consult with a healthcare professional for specific guidance on administration, dosage, and potential side effects. As with any vaccine, there may be risks and benefits associated with its use. It is essential to discuss any concerns or questions with a qualified healthcare professional before receiving the vaccine.